Focus: Innova Therapeutics is a public biotech company founded in 2020 headquartered in Mt. Pleasant, SC, with a diversified portfolio spanning oncology, radiopharmaceuticals, and cell therapy. The company operates across multiple therapeutic areas with both marketed products and early-stage pipeline programs.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Innova Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead marketed product currently at peak sales; primary revenue driver for the company.
Help build intelligence for Innova Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Innova Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Key marketed product with loss of exclusivity approaching; revenue at risk without pipeline replacement.
Multi-indication talc product nearing patent cliff; limited differentiation from other portfolio talc products.
Generic radiopharmaceutical diagnostic agent; post-LOE product with limited growth potential.
No open positions listed yet.
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo